Nine states are considering legislation to create boards to review prescription drug prices and intervene to lower them if drugs become too expensive or if their prices spike. Although the bills’ implications for the 340B program have not been fully fleshed out, Colorado covered entity Denver Health has obtained changes to a bill in that state making it more 340B-friendly.
The bills are primarily based on model legislation created by the National Academy for State Health Policy (NASHP), a nonprofit, nonpartisan forum of state health care policymakers. Many contain nearly identical provisions. They would create what are known as prescription drug affordability boards (PDABs).
Nine states are considering legislation to create boards to review prescription drug prices and intervene to lower them if drugs become too expensive or if their prices spike. Although the board’s implications for the 340B program have not been fully fleshed out, Colorado covered entity Denver Health has obtained changes to a bill in that state making it more 340B-friendly.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
